Cape Investment Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
AP
CA
Cape Investment Advisory's GILD Position: Q3 2026 in Review
Cape Investment Advisory increased its Gilead Sciences (GILD) stake by 4.9% in Q3 2026, buying an estimated $6.17K and bringing the position to 948 shares worth $141K. The position accounts for 0.04% of the portfolio, ranked #297.
Cape Investment Advisory first reported a position in GILD in Q1 2023 and has held it in 14 quarters since. 266 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Cape Investment Advisory held 948 shares of Gilead Sciences worth $141K as of Q3 2026.
- Cape Investment Advisory bought 44 Gilead Sciences shares in Q3 2026, an estimated $6.17K.
- Gilead Sciences made up 0.04% of Cape Investment Advisory's portfolio in Q3 2026, its #297 holding.
- Cape Investment Advisory first reported a position in Gilead Sciences in Q1 2023 and has held it in 14 quarters since.
- 266 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Cape Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.